av/profound-medical--big.svg

NASDAQ:PROF

Profound Medical Corp.

  • Stock

USD

Last Close

10.15

24/05 19:59

Market Cap

257.25M

Beta: 1.26

Volume Today

11.47K

Avg: 24.14K

PE Ratio

−6.25

PFCF: −8.27

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scann...Show More

Earnings

Earnings per Share (Estimate*)

-10-8-6-4-22014-12-312017-03-062019-03-072021-03-022023-03-07

Revenue (Estimate*)

1M2M3M4M2014-12-312017-03-062019-03-072021-03-022023-03-07

*Estimate based on analyst consensus